| Characteristics | % of patients (n = 54*) or Mean ± SD | Global polyuria | p-value** (c2) | |
| Absent (n = 47) | Present (n = 7) | |||
| Location |
|
|
|
|
| Niterói | 38.9 | 90.5 | 9.5 | 0.854 |
| Petrópolis | 61.1 | 84.8 | 15.2 | |
| Age |
|
|
|
|
| Under 60 years | 40.7 | 90.9 | 9.1 | 0.772 |
| 60 years or older | 59.3 | 84.4 | 15.6 | |
| Education |
|
|
|
|
| Up to incomplete primary school | 51.9 | 85.7 | 14.3 | 1.000 |
| At least completed primary school | 48.1 | 88.5 | 11.5 | |
| Hesitation |
|
|
|
|
| Absent | 88.9 | 85.4 | 14.6 | 0.720 |
| Present | 11.1 | 100 | 0 | |
| Slow stream |
|
|
|
|
| Absent | 72.2 | 84.6 | 15.4 | 0.688 |
| Present | 27.8 | 93.3 | 6.7 | |
| Feeling of incomplete bladder emptying |
|
|
|
|
| Absent | 35.2 | 94.7 | 5.3 | 0.414 |
| Present | 64.8 | 82.9 | 17.1 | |
| Post-voiding incontinence |
|
|
|
|
| Absent | 61.1 | 84.8 | 15.2 | 0.854 |
| Present | 38.9 | 90.5 | 9.5 | |
| Pelvic organ prolapse (symptom) |
|
|
|
|
| Absent | 68.5 | 86.5 | 13.5 | 1.000 |
| Present | 31.5 | 88.2 | 11.8 | |
| Anterior vaginal wall prolapse |
|
|
|
|
| Up to stage II | 90.7 | 85.7 | 14.3 | 0.836 |
| Stage III or IV | 9.3 | 100.0 | 0.0 | |
| Posterior vaginal wall prolapse |
|
|
|
|
| Up to stage II | 96.3 | 86.5 | 13.5 | 1.000 |
| Stage III or IV | 3.7 | 100 | 0 | |
| Apical prolapse |
|
|
|
|
| Up to stage II | 96.3 | 86.5 | 13.5 | 1.000 |
| Stage III or IV | 3.7 | 100.0 | 0.0 | |
| Fecal incontinence |
|
|
|
|
| Absent | 90.7 | 85.7 | 14.3 | 0.836 |
| Present | 9.3 | 100.0 | 0.0 | |
| Constipation (Bristol stool scale) |
|
|
|
|
| Absent | 75.9 | 90.2 | 9.8 | 0.440 |
| Present | 24.1 | 76.9 | 23.1 | |
| Constipation (bowel movement frequency) |
|
|
|
|
| Absent | 77.8 | 92.9 | 7.1 | 0.058 |
| Present | 22.2 | 66.7 | 33.3 | |
| Recurrent urinary tract infection |
|
|
|
|
| Absent | 81.5 | 93.2 | 6.8 | 0.022 |
| Present | 18.5 | 60.0 | 40.0 | |
| Systemic arterial hypertension |
|
|
|
|
| Absent | 37.0 | 90.0 | 10.0 | 0.938 |
| Present | 63.0 | 85.3 | 14.7 | |
| Diabetes mellitus |
|
|
|
|
| Absent | 64.8 | 88.6 | 11.4 | 0.975 |
| Present | 35.2 | 84.2 | 15.8 | |
| Heart failure |
|
|
|
|
| Absent | 96.3 | 86.5 | 13.5 | 1.000 |
| Present | 3.7 | 100.0 | 0.0 | |
| Chronic kidney disease |
|
|
|
|
| Absent | 94.4 | 88.2 | 11.8 | 0.844 |
| Present | 5.6 | 66.7 | 33.3 | |
| Chronic venous insufficiency |
|
|
|
|
| Absent | 64.8 | 88.6 | 11.4 | 0.975 |
| Present | 35.2 | 84.2 | 15.8 | |
| Depression/Anxiety |
|
|
|
|
| Absent | 85.2 | 89.1 | 10.9 | 0.598 |
| Present | 14.8 | 75.0 | 25.0 | |
| Number of comorbidities |
|
|
|
|
| Up to 2 comorbidities | 20.4 | 100.0 | 0.0 | 0.352 |
| 3 or more | 79.6 | 83.7 | 16.3 | |
| Antidepressant |
|
|
|
|
| Absent | 81.5 | 88.6 | 11.4 | 0.832 |
| Present | 18.5 | 80.0 | 20.0 | |
| Diuretic |
|
|
|
|
| Absent | 70.4 | 86.8 | 13.2 | 1.000 |
| Present | 29.6 | 87.5 | 12.5 |
|
| Calcium channel blocker |
|
|
|
|
| Absent | 75.9 | 82.9 | 17.1 | 0.261 |
| Present | 24.1 | 100.0 | 0.0 | |
| Benzodiazepine |
|
|
|
|
| Absent | 88.9 | 85.4 | 14.6 | 0.720 |
| Present | 11.1 | 100 | 0 | |
| Angiotensin II receptor blocker |
|
|
|
|
| Absent | 53.7 | 86.2 | 13.8 | 1.000 |
| Present | 46.3 | 88.0 | 12.0 | |
| Beta blocker |
|
|
|
|
| Absent | 81.5 | 86.4 | 13.6 | 1.000 |
| Present | 18.5 | 90.0 | 10.0 | |
| Hypoglycemic agent |
|
|
|
|
| Absent | 64.8 | 88.6 | 11.4 | 0.975 |
| Present | 35.2 | 84.2 | 15.8 | |
| Insulin |
|
|
|
|
| Absent | 94.4 | 90.2 | 9.8 | 0.049 |
| Present | 5.6 | 33.3 | 66.7 | |
| Angiotensin-converting enzyme inhibitor |
|
|
|
|
| Absent | 92.6 | 86.0 | 14.0 | 0.977 |
| Present | 7.4 | 100 | 0 | |
| Polypharmacy |
|
|
|
|
| Up to 4 medications | 63.0 | 94.1 | 5.9 | 0.110 |
| 5 or more medications | 37.0 | 75.0 | 25.0 | |
| Body mass index |
|
|
|
|
| Normal | 16.7 | 66.7 | 33.3 | 0.040 |
| Overweight | 27.8 | 80.0 | 20.0 | |
| Obesity | 55.6 | 96.7 | 3.3 | |
| Risk of obstructive sleep apnea |
|
|
|
|
| Low | 31.5 | 82.4 | 17.6 | 0.796 |
| Moderate or high | 68.5 | 89.2 | 10.8 | |
| Stress urinary incontinence |
|
|
|
|
| Absent | 87.0 | 87.2 | 12.8 | 1.000 |
| Present | 13.0 | 85.7 | 14.3 | |
| Urgency urinary incontinence |
|
|
|
|
| Absent | 88.9 | 85.4 | 14.6 | 0.720 |
| Present | 11.1 | 100 | 0 |
|
| Mixed urinary incontinence |
|
|
|
|
| Absent | 29.6 | 93.8 | 6.2 | 0.611 |
| Present | 70.4 | 84.2 | 15.8 | |
| Overactive bladder syndrome |
|
|
|
|
| Absent | 14.8 | 87.5 | 12.5 | 1.000 |
| Present | 85.2 | 87.0 | 13.0 | |
| Quantitative characteristics: |
|
|
|
|
| Caffeine (mg/day)*** | 153.2 ± 71.3 | 154.0 ± 70.3 | 150.0 ± 84.2 | 0.728 |
| Tobacco (packs/year)*** | 4.2 ± 10.9 | 3.3 ± 8.3 | 10.4 ± 22.1 | 0.046 |